WASHINGTON — After defending the Trump administration’s dramatic health cuts as a solution to bureaucratic bloat, the health department’s leaders are beginning to realize that a demoralized, diminished workforce will not help them achieve their goals.
Health and Human Services Secretary Robert F. Kennedy Jr. fired around 3,500 workers from the Food and Drug Administration last year. He’s now aiming to hire more than 3,200, including scientific reviewers and investigators. As of late April, the FDA has hired about 350.
HHS leaders have now acknowledged that earning the trust of and retaining staff is a priority. Spokesperson Andrew Nixon said the FDA is “actively investing in its workforce to ensure continuity of expertise and prevent the loss of critical institutional knowledge.” Marty Makary, the FDA commissioner, has touted the plan in media appearances and town halls over the past few months.
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.
Already have an account? Log in
